Early research (Phase 1)Study completedNCT01331135What this trial is testingAflac ST0901 CHOANOME - Sirolimus in Solid TumorsWho this might be right forEwing's SarcomaOsteosarcomaAstrocytoma+13 more Emory University 18
Testing effectiveness (Phase 2)Study completedNCT00213278What this trial is testingPhase 2 Study of Vinblastine in Children With Recurrent or Refractory Low Grade GliomaWho this might be right forGlioma The Hospital for Sick Children 50
Early research (Phase 1)Looking for participantsNCT06674265What this trial is testingSafety and Efficacy of Systemic Allogenic NK Cells in R/R NeuroblastomaWho this might be right forNeuroblastoma, Recurrent, RefractoryNeuroblastoma (NB)Neuroblastoma in Children Marzieh Ebrahimi 10
Testing effectiveness (Phase 2)Study completedNCT04047017What this trial is testingCamrelizumab Combined With Apatinib for Recurrent Resistant GTNWho this might be right forGestational Trophoblastic Disease Peking Union Medical College Hospital 20
Testing effectiveness (Phase 2)Study completedNCT03233204What this trial is testingOlaparib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With Defects in DNA Damage Repair Genes (A Pediatric MATCH Treatment Trial)Who this might be right forAdvanced Malignant Solid NeoplasmAnn Arbor Stage III Childhood Non-Hodgkin LymphomaAnn Arbor Stage IV Childhood Non-Hodgkin Lymphoma+33 more National Cancer Institute (NCI) 6
Early research (Phase 1)Study completedNCT00287885What this trial is testingDocetaxel in Treating Patients With Refractory or Recurrent Advanced Gynecologic CancerWho this might be right forCervical CancerEndometrial CancerFallopian Tube Cancer+5 more Masonic Cancer Center, University of Minnesota 18
Not applicableNot Yet RecruitingNCT07028008What this trial is testingEvaluate the Safety and Efficacy of Autologous Tumor-infiltrating Lymphocyte in Patients With Refractory Melanoma Who Failed to Immune Checkpoint InhibitorsWho this might be right forMelanoma Samsung Medical Center 9
Testing effectiveness (Phase 2)Active Not RecruitingNCT03794349What this trial is testingIrinotecan Hydrochloride, Temozolomide, and Dinutuximab With or Without Eflornithine in Treating Patients With Relapsed or Refractory NeuroblastomaWho this might be right forHigh Risk NeuroblastomaRecurrent NeuroblastomaRefractory Neuroblastoma Children's Oncology Group 94
Testing effectiveness (Phase 2)UnknownNCT00021385What this trial is testingSqualamine Lactate Plus Carboplatin in Treating Patients With Recurrent or Refractory Stage III or Stage IV Ovarian CancerWho this might be right forOvarian Cancer Jonsson Comprehensive Cancer Center
Testing effectiveness (Phase 2)Ended earlyNCT01884740What this trial is testingIntraarterial Infusion Of Erbitux and Bevacizumab For Relapsed/Refractory Intracranial Glioma In Patients Under 22Who this might be right forGlioblastoma MultiformeFibrillary Astrocytoma of BrainGlioma of Brainstem+5 more Weill Medical College of Cornell University 13
Testing effectiveness (Phase 2)Looking for participantsNCT06721689What this trial is testingPEEL-224, Vincristine and Temozolomide in Pediatric Solid TumorsWho this might be right forRefractory Solid TumorsRelapsed Solid TumorsRelapsed Neuroblastoma+3 more Theodore Laetsch 59
Early research (Phase 1)Study completedNCT03107988What this trial is testingNANT 2015-02: A Phase 1 Study of Lorlatinib (PF-06463922)Who this might be right forNeuroblastoma New Approaches to Neuroblastoma Therapy Consortium 65
Not applicableEnded earlyNCT01954576What this trial is testingNovoTTF Therapy in Treating Patients With Recurrent Glioblastoma MultiformeWho this might be right forGlioblastomaBrain Neoplasms University of Florida 21
Testing effectiveness (Phase 2)Study completedNCT02626364What this trial is testingStudy of Crenolanib in Recurrent/Refractory Glioblastoma With PDGFRA Gene AmplificationWho this might be right forRecurrent/Refractory Glioblastoma Arog Pharmaceuticals, Inc. 11
Testing effectiveness (Phase 2)Active Not RecruitingNCT05286801What this trial is testingTiragolumab and Atezolizumab for the Treatment of Relapsed or Refractory SMARCB1 or SMARCA4 Deficient TumorsWho this might be right forAtypical Teratoid/Rhabdoid TumorEpithelioid SarcomaKidney Medullary Carcinoma+15 more National Cancer Institute (NCI) 86
Not applicableStudy completedNCT00060021What this trial is testingAcupuncture in Treating Mucositis-Related Pain Caused by Chemotherapy in Patients Undergoing Stem Cell TransplantationWho this might be right forCancer National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Looking for participantsNCT04903899What this trial is testing177Lutetium-DOTATATE in Children With Primary Refractory or Relapsed High-risk NeuroblastomaWho this might be right forNeuroblastoma RecurrentNeuroblastoma Jakob Stenman 24
Early research (Phase 1)Not Yet RecruitingNCT07713732What this trial is testingTLN-499 in Combination With Venetoclax in Patients With Relapsed/Refractory Solid TumorsWho this might be right forSmall Cell Lung Cancer ( SCLC )Neuroendocrine CancerMalignant Pleural Mesotheliomas (Mpm)+1 more Treeline Biosciences, Inc. 120
Early research (Phase 1)Study completedNCT00363272What this trial is testingIspinesib in Treating Young Patients With Relapsed or Refractory Solid Tumors or LymphomaWho this might be right forChildhood Burkitt LymphomaChildhood Central Nervous System Germ Cell TumorChildhood Choroid Plexus Tumor+22 more National Cancer Institute (NCI) 30
Early research (Phase 1)Study completedNCT00217412What this trial is testingVorinostat With or Without Isotretinoin in Treating Young Patients With Recurrent or Refractory Solid Tumors, Lymphoma, or LeukemiaWho this might be right forChildhood Acute Promyelocytic Leukemia (M3)Childhood Atypical Teratoid/Rhabdoid TumorChildhood Burkitt Lymphoma+16 more National Cancer Institute (NCI) 60